{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:17:23Z","timestamp":1785403043979,"version":"3.56.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217091","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T18:40:49Z","timestamp":1558636849000},"page":"e0217091","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-8965","authenticated-orcid":true,"given":"Tereza","family":"Masonou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-2485","authenticated-orcid":true,"given":"David A.","family":"Hokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-9269","authenticated-orcid":true,"given":"Timothy","family":"Lahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-9971","authenticated-orcid":true,"given":"Luis C.","family":"Berrocal-Almanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy F.","family":"Wieland-Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Lalvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Fordham","family":"von Reyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"ref1","unstructured":"WHO. Global Tuberculosis Report. 2017;(2017):1\u20134."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijid.2019.02.036","article-title":"International Journal of Infectious Diseases A Breath of Fresh Air: BCG Prevents Adult Pulmonary Tuberculosis","volume":"80","author":"D De Gijsel","year":"2019","journal-title":"Int J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.12688\/f1000research.16521.1","article-title":"Research and development of new tuberculosis vaccines:: a review","volume":"7","author":"LK Schrager","year":"2018","journal-title":"F1000Research"},{"issue":"43","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"GM Knight","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/656332","article-title":"Interferon \u03b3 Responses to Mycobacterial Antigens Protect against Subsequent HIV\u2010Associated Tuberculosis","volume":"202","author":"T Lahey","year":"2010","journal-title":"J Infect Dis"},{"issue":"48","key":"ref6","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania","volume":"28","author":"T Lahey","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB Gold in-Tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"JR Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","first-page":"1","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: Systematic review and meta-analysis","volume":"349","author":"A Roy","year":"2014","journal-title":"BMJ"},{"issue":"9493","key":"ref9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"LC Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"9019","key":"ref10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","author":"PEM Fine","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"E Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"ref12","article-title":"H4:IC31\/BCG Revaccination POI Trial Results","author":"A. Ginsberg","year":"2018"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille-Gu\u00e9rin-primed, HIV-infected adults boosted Calmette\u2013Gue with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"CF von Reyn","year":"2010","journal-title":"AIDS"},{"issue":"17","key":"ref14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"S D. Phase 2b Controlled Trial of M72\/AS01 E Vaccine to Prevent Tuberculosis","volume":"379","author":"O. Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"issue":"32","key":"ref15","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Scriba T. Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"A. Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168521","article-title":"Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis","volume":"11","author":"T Lahey","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0175215","article-title":"Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901","volume":"12","author":"CF von Reyn","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"ref18","first-page":"4195","article-title":"Tuberculosis: Latency and Reactivation minireview Tuberculosis","volume":"69","author":"JL Flynn","year":"2001","journal-title":"Latency and Reactivation"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0088149","article-title":"Evidence for a Role for Interleukin-17, Th17 Cells and Iron Homeostasis in Protective Immunity against Tuberculosis in Cynomolgus Macaques","volume":"9","author":"AS Wareham","year":"2014","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"HA Fletcher","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load","volume":"187","author":"C. L. Day","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-\u03b1+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"A Harari","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Gu\u00e9rin Vaccination of Newborns","volume":"182","author":"BMN Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2011.02.010","article-title":"Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells","volume":"29","author":"SC Derrick","year":"2011","journal-title":"Vaccine"},{"issue":"30","key":"ref25","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"H-W Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice","volume":"181","author":"EK Forbes","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG DureC hly1 Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses","volume":"204","author":"C Desel","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"L Grode","year":"2013","journal-title":"Vaccine"},{"issue":"30","key":"ref30","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4: IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial","volume":"33","author":"H Geldenhuys","year":"2015","journal-title":"Vaccine"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques","volume":"22","author":"AD White","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00421","article-title":"Increased TNF-\u03b1\/IFN-\u03b3\/IL-2 and Decreased TNF-\u03b1\/IFN-\u03b3 Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination","volume":"7","author":"MF Maggioli","year":"2016","journal-title":"Front Immunol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.1400676","article-title":"Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge","volume":"193","author":"PA Darrah","year":"2014","journal-title":"J Immunol"},{"key":"ref34","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","author":"SG Hansen","year":"2018","journal-title":"Nat Publ Gr"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.201141569","article-title":"IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination","volume":"42","author":"R Gopal","year":"2012","journal-title":"Eur J Immunol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2014.11.013","article-title":"BCG vaccination-induced long-lasting control of Mycobacteriumtuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+","volume":"33","author":"A Cruz","year":"2015","journal-title":"T cells. Vaccine"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"SA Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/infdis\/jit002","article-title":"Role of the Interleukin 10 Family of Cytokines in Patients With Immune Reconstitution In fl ammatory Syndrome Associated With HIV Infection and Tuberculosis","volume":"207","author":"R Tadokera","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17 and IL-22-producing CD4 + T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"TJ Scriba","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/imm.12130","article-title":"Mice genetically inactivated in interleukin-17a receptor are defective in long-term control of mycobacterium tuberculosis infection","volume":"140","author":"D Freches","year":"2013","journal-title":"Immunology"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: From diagnosis to protection","volume":"8","author":"D Goletti","year":"2016","journal-title":"Infect Dis Rep"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1371\/journal.pone.0057379","article-title":"IL-22 Is Mainly Produced by IFN\u03b3-Secreting Cells but Is Dispensable for Host Protection against Mycobacterium tuberculosis Infection","volume":"8","author":"J Behrends","year":"2013","journal-title":"PLoS One"},{"issue":"9871","key":"ref43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"issue":"25","key":"ref44","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2015.03.070","article-title":"A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants","volume":"33","author":"M Tameris","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087340","article-title":"The candidate TB vaccine, MVA85A, induces highly durable Th1 responses","volume":"9","author":"M Tameris","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cyto.a.22478","article-title":"OMIP-022: Comprehensive Assessment of Antigen-Specific Human T Cell Functionality and Memory","volume":"85","author":"AJ Graves","year":"2014","journal-title":"Cytom Part A"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1292","article-title":"Direct access to CD4+ T cells specific for defined antigens according to CD154 expression","volume":"11","author":"M Frentsch","year":"2005","journal-title":"Nat Med"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0022074","article-title":"Polyantigenic Interferon-\u03b3 Responses Are Associated with Protection from TB among HIV-Infected Adults with Childhood BCG Immunization","volume":"6","author":"T Lahey","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0035-9203(88)90003-X","article-title":"Leprosy in Malawi Prevention Trial: Background, design and prospects of the Karonga leprosy vaccine trial in northern Malawi","volume":"82","author":"PEM Fine","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0962-8479(92)90043-J","article-title":"Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile","author":"RL Sepulveda","year":"1992","journal-title":"Tuber Lung Dis"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"C Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:44:01Z","timestamp":1589031841000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217091"}},"subtitle":[],"editor":[{"given":"Angelo A.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217091","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}